Showing 81 - 90 of 270 results
Enhancing Clinical Awareness in LTC
This program explores the prevalence, impact, and symptoms of agitation associated with dementia due to Alzheimer’s disease, specifically focusing on patients living in a long-term care setting. Participants will review the current clinical care landscape for treatment of agitation associated with dementia due to Alzheimer's disease. The program will also provide an overview of the Centers for Medicare & Medicaid Services Regulations on Antipsychotics.
Read MoreExcellence in Long Term Care - Annual Conference
Charlottesville, VADoubleTree by Hilton - Charlottesville
Read MoreExcellence in Long Term Care - VA Chapter's Annual Conference
Glen Allen, VAThe Excellence in Long Term Care Conference is an educational event dedicated to advancing quality, safety, and innovation across the long-term and post-acute care continuum. Designed for Physicians, Physician Assistants, Nurse Practitioners, Pharmacists, Facility Administrators, and other healthcare professionals, the conference brings together clinical and operational leaders to address the complex needs of aging and medically vulnerable populations. Through evidence-based presentations, practical case discussions, and collaborative learning, attendees gain actionable insights on best practices in patient care, regulatory compliance, interdisciplinary teamwork, and emerging trends shaping long-term and post-acute care delivery.
Read MoreFirst-Line Prescription Treatment for Hallucinations and Delusions Associated with Parkinson's Disease Psychosis in the LTC Setting
Hallucinations and delusions are common, underreported nonmotor symptoms of Parkinson's disease (PD) that can significantly impact patients and caregivers. Attempting to manage hallucinations and delusions in patients with PD can present a therapeutic bind. Join Malcolm Fraser, MD, CMD, for a presentation exploring these challenges as well as a review of the clinical efficacy and safety of a treatment option. Additionally, real-world evidence from 2 retrospective analyses investigating the risk of all-cause mortality among patients with PD psychosis treated with atypical antipsychotics will be presented.
First-Line Prescription Treatment for Hallucinations and Delusions Associated With Parkinson’s Disease Psychosis in the LTC Setting
Hallucinations and delusions are common, underreported nonmotor symptoms of Parkinson’s disease (PD) that can significantly impact patients and caregivers. Attempting to manage hallucinations and delusions in patients with PD can present a therapeutic bind.
Read More